US Stocks
/
Artiva Biotherapeutics, Inc. Share Price
Artiva Biotherapeutics, Inc. Share Price

Artiva Biotherapeutics, Inc. Share Price

NASDAQ: ARTV | Micro Cap
$6.81
-$0.21 (-2.99%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Artiva Biotherapeutics, Inc. Stock Performance

Open
$6.71
Prev. Close
$7.02
Circuit Range
N/A
Day Range
$6.58 - $6.89
Year Range
$2.73 - $14.47
Volume
10,039
Average Traded
$6.79

Artiva Biotherapeutics, Inc. Share Price Today

As of 9 October 2026, Artiva Biotherapeutics, Inc.'s share price is $6.81. The stock opened at $6.71, compared to its previous close of $7.02. During today's trading session, Artiva Biotherapeutics, Inc.'s share price traded between $6.58 and $6.89, with an average price of $6.74. Over the past 52 weeks, the stock has recorded a high of $14.47 and a low of $2.73. In terms of performance, Artiva Biotherapeutics, Inc.'s share price has declined by 33.69% over the last six months and is up 61.37% on a year-on-year basis.

Artiva Biotherapeutics, Inc. Share Price Chart

$6.58$6.89
L
Show Current Price
H

Artiva Biotherapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$166.46M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.86
Revenue (TTM)
$0.00
Return On Equity (TTM)
-26.14%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-16.16%

Artiva Biotherapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$21.53-$20.77-$23.52-$25.01
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A3.53%-13.24%-6.34%

Artiva Biotherapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.25$0.00
Net Profit-$65.37-$83.87
Net Profit Margin-26148.00%N/A
Income ChangeN/A-28.30%

About Artiva Biotherapeutics, Inc.

Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).

Artiva Biotherapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$6.92
$6.82
-4.08%
Sep 2026
$11.06
$7.11
-40.50%
Aug 2026
$10.08
$11.95
+18.61%
Jul 2026
$9.75
$10.07
+3.76%
Jun 2026
$7.68
$9.71
+22.76%
May 2026
$9.90
$7.91
-22.98%
Apr 2026
$6.35
$10.27
+59.10%
Mar 2026
$5.54
$6.46
+8.31%
Feb 2026
$3.99
$5.96
+52.43%
Jan 2026
$4.17
$3.91
-8.64%
Dec 2025
$3.58
$4.28
+16.94%
Nov 2025
$4.18
$3.66
-13.27%

ARTV Share Price FAQs

What is Artiva Biotherapeutics, Inc. share price today?

chevron-up
Artiva Biotherapeutics, Inc. share price today is $6.81 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Artiva Biotherapeutics, Inc. stock?

chevron-up
The 52 week high of Artiva Biotherapeutics, Inc. stock is $14.47, while the 52 week low is $2.73 as of 9 Oct '26.

What is ARTV's market capitalisation today?

chevron-up
ARTV market capitalisation is $166.46M as of October 9, 2026, at 6:11 pm IST.

What is ARTV's net income for the last quarter?

chevron-up
ARTV's net income for the last quarter is -25.01B USD.

What is the 5 year returns of ARTV?

chevron-up
The 5 year returns of ARTV is -42.24% as on 9 Oct '26.

What is the high & low stock price of ARTV today?

chevron-up
ARTV stock price hit a high of $6.89 and low of $6.58 as of 9 Oct '26.

Can I buy ARTV shares in India?

chevron-up
Yes. You can buy ARTV in India by opening an international trading account.